Patents by Inventor René Hersperger

René Hersperger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl carboxylic acid cyclohexyl amide derivatives
    Patent number: 8354431
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: (I) wherein the variants R and X are defined in the specification.
    Type: Grant
    Filed: February 18, 2008
    Date of Patent: January 15, 2013
    Assignee: Novartis AG
    Inventors: Rene Hersperger, Philipp Janser, Wolfgang Miltz
  • Chemokine receptor antagonists
    Patent number: 8183366
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: May 22, 2012
    Assignee: Novartis AG
    Inventors: Rene Hersperger, Philipp Janser, Emil Pfenninger, Hans J Wuethrich, Wolfgang Miltz
  • Chemokine receptor antagonists
    Publication number: 20110015180
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
    Type: Application
    Filed: September 20, 2010
    Publication date: January 20, 2011
    Inventors: René Hersperger, Philipp Janser, Emil Pfenninger, Hans Juerg Wuethrich, Wolfgang Miltz
  • Chemokine receptor antagonists
    Patent number: 7858781
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
    Type: Grant
    Filed: February 10, 2005
    Date of Patent: December 28, 2010
    Assignee: Novartis AG
    Inventors: René Hersperger, Philipp Janser, Emil Pfenninger, Hans Juerg Wuethrich, Wolfgang Miltz
  • ARYL CARBOXYLIC ACID CYCLOHEXYL AMIDE DERIVATIVES
    Publication number: 20100016361
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: (I) wherein the variants R and X are defined in the specification.
    Type: Application
    Filed: February 18, 2008
    Publication date: January 21, 2010
    Inventors: Rene Hersperger, Philipp Janser, Wolfgang Miltz
  • IMIDAZO PYRIDINE DERIVATIVES
    Publication number: 20090291942
    Abstract: The invention relates to novel imidazopyridine derivatives and to their use in the treatment of diseases and disorders which may e.g. involve angiogenesis and/or pain, including autoimmune and inflammatory diseases.
    Type: Application
    Filed: May 19, 2009
    Publication date: November 26, 2009
    Inventors: Ivan Cornella Taracido, Edmund Martin Harrington, René Hersperger, René Lattmann, Wolfgang Miltz, Klaus Weigand
  • 2-aminopyrimidine derivatives and their medical use
    Patent number: 7615562
    Abstract: A compound of formula I or a pharmaceutically acceptable salt, ester or prodrug thereof wherein the variables have the meanings as defined in the specification. Further disclosed are a method of inhibiting IKK activity using a compound of formula I, a method of inhibiting production of TNF using a compound of formula I, a compound of formula I for use as a pharmaceutical, a pharmaceutical composition comprising a compound of formula I, and use of a compound of formula I in the manufacture of a medicament for use as an immunosuppressant or anti-inflammatory agent.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: November 10, 2009
    Assignee: Novartis AG
    Inventors: Birgit Bollbuck, Alastair DenholmMritain, Jörg Eder, René Hersperger, Philipp Janser, Lászlo Révész, Achim Schlapbach, Rudolf Wálchi
  • Chemokine receptor antagonists
    Publication number: 20070155721
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
    Type: Application
    Filed: February 10, 2002
    Publication date: July 5, 2007
    Inventors: Rene Hersperger, Philipp Janser, Emil Pfenninger, Hans Wuethrich, Wolfgang Miltz
  • 2-Aminopyrimidine derivatives and their medical use
    Publication number: 20070043048
    Abstract: A compound of formula I or a pharmaceutically acceptable salt, ester or prodrug thereof wherein the variables have the meanings as defined in the specification. Further disclosed are a method of inhibiting IKK activity using a compound of formula I, a method of inhibiting production of TNF using a compound of formula I, a compound of formula I for use as a pharmaceutical, a pharmaceutical composition comprising a compound of formula I, and use of a compound of formula I in the manufacture of a medicament for use as an immunosuppressant or anti-inflammatory agent.
    Type: Application
    Filed: April 8, 2004
    Publication date: February 22, 2007
    Inventors: Birgit Bollbuck, Alastair DenholMritain, Laszlo Revesz, Achim Schlapbach, Rudolf Walchli, Jorg Eder, Rene Hersperger, Philipp Janser
  • Naphthyridine derivatives
    Patent number: 6136821
    Abstract: Novel 8-aryl-1,7-naphthyridines, in free or salt form, are PDE IV inhibitors and are thus useful as pharmaceuticals, e.g. for asthma therapy. Preferred compounds include compounds of formulae (I and II) wherein the R groups are as defined. Pharmaceutical compositions comprising the compounds, processes for preparation of the compounds and novel intermediates for use in the processes are disclosed.
    Type: Grant
    Filed: April 27, 1999
    Date of Patent: October 24, 2000
    Assignee: Novartis AG
    Inventor: Rene Hersperger
  • Ascomycins
    Patent number: 5925649
    Abstract: The invention provides novel ascomycins bearing one or more physiologically hydrolyzable and acceptable oxycarbonyl moieties or carboxy moieties, such compounds being found useful as pharmaceuticals, especially in the treatment of asthma an dermatitis. Methods of producing the compounds and pharmaceutical compositions comprising the compounds are also provided.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: July 20, 1999
    Assignee: Novartis AG
    Inventors: Rene Hersperger, Reto Naef